Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy

This study has been completed.
Information provided by:
National Eye Institute (NEI) Identifier:
First received: December 13, 2006
Last updated: November 9, 2010
Last verified: November 2010